Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Pembrolizumab and Paclitaxel in Hormone Receptor-positive, hyperMUTATted Metastatic Breast Cancer Identified by Whole exOme sequeNcing ('MUTATION2')

Yonsei University · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
breastcancerpembrolizumabpositive
breast cancer, pembrolizumab, hypermutated, hormone receptor-positive, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 979345
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.